Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.05%
#2 Audiera Audiera +19.18%
#3 Geodnet Geodnet +10.71%
#4 Ocean Protocol Ocean Protocol +8.89%
#5 The Bitcoin Bull The Bitcoin Bull +6.72%
#6 Rollbit Coin Rollbit Coin +6.51%
#7 Quack AI Quack AI +5.98%
#8 Cysic Cysic +5.70%
#9 Bityuan Bityuan +4.52%
#10 Tutorial Tutorial +4.12%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Settings
Language
ENGLISH
Currency
USD
Theme
Fermentalg S.A. Fermentalg S.A.

Fermentalg S.A.

FALG
Rank in Stocks #32559
Fermentalg S.A. is a French enterprise that develops, produces, and markets... Fermentalg S.A. is a French enterprise that develops, produces, and markets active compounds derived from microalgae, serving the global food, health, and nutrition sectors. Its product lineup features DHA ORIGINS, a plant-based DHA oil; PROTEALG, a vegetable protein; and BLUE ORIGIN, a natural colorant alternative for human dietary applications. Additionally, Fermentalg offers carbon capture solutions designed to sequester CO2 in urban and industrial environments. Founded in 2009, the company is headquartered in Libourne, France.
Share Price
$0.54273059
Last synced: 2024-05-13
Market Cap
$9.77M
Change (1 day)
-0.57%
Change (1 year)
0.00%
Country
FR
Trade Fermentalg S.A. (FALG)

Category

Healthcare
Revenue for Fermentalg S.A. (FALG)
Revenue in Aug 2026 TTM: 0
According to Fermentalg S.A. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Fermentalg S.A. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE